The group called shareholders for November 16 to vote on authorizing the Board of Directors to increase the share capital by up to 20% over the next 18 months.
This initiative is intended to secure the necessary shareholder mandate for the Company to carry out, if and when market conditions and investment opportunities warrant, a share capital increase through the issuance of new shares representing, in aggregate, up to 20% of the Company’s share capital, over a period of up to 18 months.
The purpose of this initiative is to provide the Group with swift and flexible access to capital-to-finance development opportunities with the potential to generate attractive long-term returns for shareholders, including organic development projects, investments in medical infrastructure and market consolidation transactions.
The implementation of any such transaction will be subject to the required corporate approvals, including approval by the General Meeting of Shareholders, the market conditions prevailing at the relevant time and the availability of investment opportunities that meet the Group’s return and financial discipline criteria.
In line with the strategic direction approved by the Board of Directors, MedLife intends to continue and accelerate its regional expansion, building on the Group’s presence in Romania, Hungary and the Republic of Moldova and gradually entering other Central and Eastern European markets, with priority given to the Balkans. This development may be pursued through acquisitions, greenfield investments, partnerships or other forms of cooperation, depending on the opportunities available and subject to the Group’s investment and return criteria.
“Healthcare is no longer solely about treatments, surgical procedures or medicines; it is also about prevention and, beyond that, longevity, physical activity, nutrition and education for a healthy lifestyle. The future of medicine lies in moving from treating disease to an integrated approach focused on prevention and on living not only longer, but healthier lives,” said Mihai Marcu, Chairman of the Board of Directors and CEO of MedLife Group.
To support this strategy, MedLife is exploring the establishment, together with a leading international financial institution, of a regional investment platform. Such a partnership could facilitate access to capital and the sharing of investment risks, while also strengthening governance and sustainability standards and enhancing the Group’s capacity to execute regional transactions.
The regional investment platform is expected to deploy capital gradually over a four-year horizon in companies operating in healthcare, prevention and wellness in Romania and the targeted Central and Eastern European markets, with priority given to the Balkans. The initiative will combine the resources and expertise of Romania’s largest private healthcare services provider with the know-how of a leading international financial institution with extensive global investment experience.
The first investments under the platform are expected to be initiated in the first half of next year, with capital deployed gradually at a pace aligned with the Group’s financial capacity and investment priorities.
“Over time, we have demonstrated excellence in organic development and in the successful integration of significant market operators, and such an investment platform would represent a natural next step in MedLife’s evolution, providing additional resources to accelerate regional development. We remain attentive to consolidation opportunities across the region and believe that MedLife’s expertise represents a significant competitive advantage in this process. Our ambition is to transform the experience already gained in Romania, Hungary and the Republic of Moldova into a consolidation model that can be applied across Central and Southeastern Europe, contributing to the development of a regional healthcare platform built on Romanian capital and expertise”, added Mihai Marcu, Chairman of the Board of Directors and CEO of MedLife Group.
MedLife reported consolidated revenue of RON1.74 billion for the first half of 2026, up 10.5% against the year-earlier period, and loss of RON34.7 million, almost three times higher than RON10.9 million reported in the same period of 2025.
(English version by Catalina Apostoiu)